Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Research in the area of cancer gene therapy reported from Wuhan University
July 15th, 2008
A new study, 'Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells,' is now available. "Gastric cancer is the fourth most common cancer in the world and the leading cause of cancer death in China. It is necessary to find a safe and effective way to treat this disease," investigators in People's Republic of China report. "A sustained overexpression of survivin is a characteristic feature of gastric cancer as it gives cancer cells a survival and growth advantage. RNA interference (RNAi), which has been proven to be a powerful tool for suppressing gene expression, may provide a promising way forward in gastric cancer therapy. Few studies have been...
Source: Cancer Weekly (2008-07-15)
|
